Clinical Trials Browser

Withdrawn × Denosumab × Clear all

NCT03532087 2020-01-18

PERIDENO

Phase 2 Withdrawn

Breast Neoplasms

NCT02101164 2015-02-18

Evaluate Time Associated With the Preparation & Administration of Denosumab/Pamidronate in Patients With Solid Tumors and Metastatic Bone Disease

Phase 4 Withdrawn

Bone Diseases